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 Ionizing radiation primarily perturbs the basic molecular level proportional to dose,
with potential damage propagation to higher levels: cells, tissues, organs, and whole body.
There are three types of defenses against damage propagation. These operate determinis-
tically and below a certain impact threshold there is no propagation. Physical-static defens-
es precede metabolic-dynamic defenses acting immediately: scavenging of toxins; - molec-
ular repair, especially of DNA; - removal of damaged cells either by apoptosis, necrosis,
phagocytosis, cell differentiation-senescence, or by immune responses, - followed by
replacement of lost elements. Another metabolic-dynamic defense arises delayed by up-reg-
ulating immediately operating defense mechanisms. Some of these adaptive protections
may last beyond a year and all create temporary protection against renewed potentially
toxic impacts also from non-radiogenic endogenous sources. Adaptive protections have a
maximum after single tissue absorbed doses around 100 to 200 mSv and disappear with
higher doses. Low dose rates initiate maximum protection likely at lower cell doses deliv-
ered repetitively at certain time intervals. Adaptive protection preventing only about 2 – 3
% of endogenous life-time cancer risk would fully balance a calculated induced cancer risk
at about 100 mSv, in agreement with epidemiological data and concordant with an hormet-
ic effect. Low-dose-risk modeling must recognize up-regulation of protection. 
Keywords: Low-dose cancer risk, adaptive protections, hormesis 
INTRODUCTION
Epidemiology so far fails to substantiate the claim of an increase in
cancer incidence in humans following low-level exposure to ionizing radi-
ation, below about 150 mGy or mSv. Rather a decrease in cancer risk has
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shown up repeatedly (Pollycove and Feinendegen 2001; Tubiana et al.
2005; Nair et al. 2009; Tubiana et al. 2009). Nevertheless, observed data
are fitted using the linear-no-threshold (LNT) hypothesis (ICRP 1977)
This hypothesis expresses proportionality between dose and risk, and is
the basis for radiation protection regulation and most widely used.
Despite contradicting epidemiological and experimental findings the
LNT hypothesis is also applied to predict cancer risks of low-dose irradia-
tion (Brenner and Hall 2007). What was a good intention years ago to
protect workers from overexposure to ionizing radiation has been turned
to producing a wide spread radiation phobia now. 
The initial plausibility of the LNT-hypothesis derived from two
assumptions: 1) immediate damages to the genetic material (DNA) from
radiation absorption increase in proportion to the absorbed dose; 2) cer-
tain immediate DNA damage is amplified and propagates in organisms to
cause the cancer incidence in an exposed population to rise in propor-
tion to dose. 
The second assumption is debatable for both epidemiological and
experimental reasons. Regarding epidemiology, data show statistical con-
straints and require very large numbers of irradiated individuals to assess
the carcinogenic risks of low doses (< 150 mSv), such large numbers are
not available at present. Thus, modeling of data with the LNT hypothesis
arrives at relative risks of cancer that are actually not observed
(Heidenreich et al. 1997; Pollycove and Feinendegen 2001; Tanooka
2001; Preston et al. 2004, 2007; Cardis et al. 2007; Nair et al. 2009; Tubiana
et al. 2009). 
The LNT hypothesis assumes its scientific justification because of the
immediate linear dose-effect relationships at the molecular level of the
DNA; it does not consider the complex non-linear dynamics of oncogen-
esis in the body. Indeed, more recent discoveries on low-dose effects in
experiments with various biological systems from cells to animals increas-
ingly show specific responses of physiological damage control systems lim-
ited to low doses at various levels of biological organization (Feinendegen
et al. 2004; Tubiana et al. 2005, 2009; Mullenders et al. 2009), and also dis-
covered a low-dose induced reduction of the incidences of neoplastic
transformation in culture cells and overt malignancies in animals (Azzam
et al. 1996; Mitchel et al. 2003, 2008; Elmore et al. 2009). Such responses
have not been observed at, and also were not expected from, high dose
radiation exposures. In fact, new findings challenge the validity of the
LNT-hypothesis, and now suggest that this hypothesis cannot be main-
tained (Tubiana et al. 2005, 2009; Feinendegen et al. 2007a,b). 
Currently, the discussion of the low-dose risk of cancer has become
polarized on how to best incorporate new findings into practical applica-
tion. A case in point is the serious disagreement between recent state-
ments by the French Academy of Sciences (Tubiana et al. 2005) and the
L. E. Feinendegen and others
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US National Academy of Sciences by way of its BEIR VII report (National
Research Council 2006). 
The present paper attempts to focus on the new radiobiological find-
ings on low-dose related cancer risk. It hypothesizes that after low dose
exposures clinical cancer develops as a consequence of the balance
between cancer induction and cancer prevention by the cascade of the
body’s physiological defenses. 
This paper emphasizes both the proportional relationship between
absorbed dose and DNA damage, and the non-linearly operating body’s
defense systems that block damage propagation from the molecular level
to the whole organism. There are at least three types of “defending” bar-
riers: a physical-static one, and two metabolic-dynamic defenses. One of
the latter two defenses responds soon after perturbation, while the other
involves delayed up-regulations of defenses in terms of adaptive respons-
es that appear with a delay of hours and last for various times up to more
than a year after low-dose exposure. Adaptive protections can operate
against both radiogenic and non-radiogenic DNA damage and its conse-
quences. Applied to the observed experimental and epidemiological
data, with their wide ranges of uncertainties, the modeling indicates not
only the inconsistency of the LNT hypothesis but also the high probabil-
ity of beneficial, i.e., hormetic effects following low-dose irradiation
(Calabrese and Baldwin 2003). 
THE MEANING OF ABSORBED DOSE IN THE LOW DOSE REGION
The term absorbed dose describes concentration and not the amount
of the energy absorbed in the exposed mass such as an organ or the
whole body (ICRU 1998;). The unit of absorbed dose (D) is the gray: 1
Gy (100 rad) = 1 J/kg. This is equivalent to 6.24 x 1015 eV per g mass, or
6.24 x 106 eV per ng mass. The unit of the equivalently effective dose from
different radiation qualitites is the sievert, Sv (ICRU 1998) At a suffi-
ciently high value of absorbed dose from an external radiation field,
absorbed dose in a large mass is identical to the absorbed dose in any
small mass of the same exposed tissue; but the total energies absorbed in
these masses are not the same (ICRU 1983).. 
The above definition of absorbed dose poses problems when it comes
to analyzing and understanding the effects both of low-dose, external
sources, exposure (ICRU 1983, 2005) as well as heterogenous exposure
to incorporated radionuclides, for instance in nulear medicine tests
(ICRU 2002). In both instances ionizing radiation causes the deposition
of energy from charged particle tracks that arise either through interac-
tion of uncharged particles with charged particles, such as photons (x- or
gamma rays) that can dislodge electrons from atomic orbitals, or through
charged particles as they may be produced by accelerators or result
directly from the decay of radionuclides (alpha-, beta-emssion). The ener-
Low-dose cancer risk modeling must recognize up-regulation of protection
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gy deposited by a single particle track in traversing a tissue micromass of
1 ng will be denoted in this paper by the term “microdose”, and the event
delivering this microdose is referred to as a “microdose event” (ICRU
1983). 
Large absorbed doses D in the tissue create large numbers of micro-
dose events per exposed micromass. The sum of energies delivered by
multiple microdoses per given micromass is here denoted “cell-dose.” As
D in the body decreases, the number of microdose events per exposed
micromass is reduced eventually below an average value of 1 per micro-
mass. Then, the dose to each micromass becomes either 0 or it will be the
microdose from a single track traversing the micromass, and only some
fractional number of micromasses experience a microdose event (see
Figure 1) (ICRU 1983). 
The microdose values compose a spectrum according to charged par-
ticle energies from a given radiation quality. This spectrum may vary by a
factor of up to 10 or more, around the mean value. According to the radi-
ation quality, the mean microdoses have defined values, as shown in Table
1 middle column. In case of exposure from incorporated radionulcides,
the overlaying and more or less severe topographical heterogeneity of
decays occurring localized in the tissue of interest makes dosimetry more
difficult and has been delt with extensively (ICRU 2002).
In the context of comparing man-made low-level exposures, for
instance in diagnostic medicine, with exposure from natural sources of
L. E. Feinendegen and others
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FIGURE 1: Scheme of particle distribution in tissues. Shown are several electrons and an alpha-par-
ticle. Clearly, total energy absorbed per unit mass correlates with the number of particles in that mass. 
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background radiation the following considerations may be helpful in risk
assessment. As an example, the exposure of tissue to 100 kVp x-rays caus-
es on average 1 electron track delivering about 6 keV per 1 ng mass - cor-
responding to the average cell mass—and the mean microdose is about 1
mGy (ICRU 1983). A body dose of 1 mGy from 100 kVp x-rays then means
an average of about 1 microdose event in each ng mass of the exposed tis-
sue. One mGy per year accordingly means that about 1 event per ng
occurs per year, or each ng experiences on average 1 microdose of 1 mGy
once about every 365 days. 
Normal background radiation causes whole body absorbed doses in
the range of several mSv per year from different radiation sources and
qualities, largely cosmic gamma rays with a relatively small contribution
from alpha irradiation coming mainly from inhaled radon. Background
radiation may vary considerably with altitude and geographic region, and
may be more than ten-fold higher than the average value at sea level in
the northern hemisphere. The above considerations imply that every ng
or cell in the body experiences a microdose event several times a year.
More specifically, taking an adult body to have 7 x 1013 ng, and a year to
have about 3.2 x 107 seconds, then, for the sake of easy calculation, an
annual whole body dose of 1 mGy from chronic exposure to x-rays caus-
es around 2.2 x 106 1 mGy-microdose events per second on average in the
Low-dose cancer risk modeling must recognize up-regulation of protection
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TABLE 1: The energy absorbed per micromass, here of 1 ng, per particle traversal is formally called
specific energy with the symbol z, and –zF1 is the fluency-derived mean value of z (33). The table gives
the value of –zF1 and the approximate number of reactive oxygen species (ROS) produced by this
value in the hit micromass. 
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whole body, and each of those events would have the potential of trigger-
ing secondary consequences. 
Such calculations are easy also for other radiation qualities than 100
kVp x-rays. The mean microdose values are displayed for a few different
types of radiation in Table 1. Thus, if the background radiation field would
be equivalent to gamma rays from 137Cs delivering about 0.4 mGy per
microdose event, chronic exposure to an annual whole body dose of 2 mGy
would cause on average 1 microdose event 5 times a year in each ng in the
body, or each ng would experience on average 1 event every 2.4 months. 
PRIMARY BIOLOGICAL INTERACTIONS
Each microdose event causes numerous atomic ionizations and exci-
tations stochastically along the particle track depending on the type of
radiation. Biological tissues consist by weight of ~ 75 % water. Hence, a
correspondingly large fraction of ionizations induce hydrolysis resulting
in different kinds of reactive oxygen species (ROS); on average about 25
ROS are produced by hydrolysis for each keV absorbed in tissue. The
number of ROS per each mean microdose event from different radiation
qualities is also listed also in Table 1, right column. In general, ROS are
both signaling molecules and can be toxic (Sen et al. 2000) depending on
concentration. When produced by irradiation ROS attack largely at ran-
dom all kinds of biochemical substrates in the immediate and in some dis-
tant molecular “neighborhood” of the site of their creation, and add to
biochemical damage by direct ionizations. 
The ROS induced by radiation are biochemically similar to those that
are constantly and abundantly produced in different cellular compart-
ments, mainly mitochondria, during normal oxidative metabolism.
Mitochondria alone let leak out some 109 ROS into the cytosol per cell
per day (Pollycove and Feinendegen 2003). One needs to consider the
effects of both endogenous and radiogenic ROS in conjunction with
direct effects especially on DNA. The combined latter effects generally
are more toxic but much less frequent than the first. Most relevant are
damages to DNA, be they from ROS, direct ionizations or from both, as
discussed further below. 
DAMAGE TO DNA AND ITS REPAIR
Biological responses to ionizing radiation, wherever they become
observable either acute or delayed, appear to always originate because of
changes in cellular molecules, especially the DNA. The immediate DNA
damage and cellular responses to it are quite well understood, and
includes inter-molecular cross links of various kinds, base changes, single
strand breaks (SSB), and the more serious double strand breaks (DSB)
(Hall and Giaccia 2005).
L. E. Feinendegen and others
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It needs be stressed that the radiation-induced immediate damages to
DNA increase linearly with dose. The reason for this linearity is the dose
dependent number of microdose events produced, and each of them caus-
es a given degree of damage according to their energy spectrum charac-
teristic for a given type of radiation. Thus, as dose increases, the number
of microdose events according to the given spectrum increases, and with
them the number of individual damage sites caused by each one of the
events. A dose effect curve for immediate DNA damage in tissue actually
conforms to a linear “Impact-Number-Effectiveness Function” without
threshold (Bond et al. 1995). This linear function though is not identical
in various cell types, and it is lost as complex biological systems respond to
low doses in various ways to the initial damages, as discussed below. 
Within minutes after irradiation there is a plethora of DNA and chro-
matin modifications involved in DNA repair (Hall and Giaccia 2005).
Immuno-histochemical methods now allow, for instance, the microscopic
observation of DNA double strand breaks in individual cells (Rothkamm and
Löbrich 2003; Sedelnikova et al. 2004). Well within 24 hours, the fluorescent
foci, supposedly indicative of double strand breaks, decrease to a lower num-
ber, closer to that of the background “spontaneous”, i.e. pre-irradiation,
number (Rothkamm and Löbrich 2003). By way of this technique one has
learned that experimentally non-irradiated cells, depending on type and age,
contain on average from about 0.1 to numerous DNA double strand breaks
at steady state, a finding strongly disputed for years (Sedelnikova et al. 2004).
In contrast, at background radiation level, the probability of a radiation
induced DNA DSB to occur per day per average cell in the human body is
about 1 in 10 000 (Pollycove and Feinendegen 2003). 
The capacity of normal cells to repair damage to DNA and other cel-
lular components is genetically determined and may vary individually.
Today, more than 150 genes have been described to be involved in DNA
repair at high and low doses (Franco et al 2005; Feinendegen et al. 2007a;
2008). Some genes are active only in low-dose stress responses; others
again are modulated only after high doses (Franco et al. 2005; Mullenders
et al. 2009; Tubiana et al. 2009). This reproducible data alone already con-
tradicts the justification of the LNT hypothesis for assessing health detri-
ment as function of low dose. Moreover, low dose irradiated confluent
cells in culture appear to stall DNA repair until cell proliferation begins
again (Rothkamm and Löbrich 2003). Indeed, an immediate induction
of DNA repair is reported in proliferating culture cells to be elevated at
low doses of about 1 mGy of x- and gamma radiation (Day et al. 2006;
Mullenders et al. 2009; Tubiana et al. 2009).
In general, then, immediate damages of DNA provoke ready attempts
at structural and functional reconstitution at the cell level. Radiation
induced effects in tissues are determined eventually by the degree of
remaining DNA- and cell damage. 
Low-dose cancer risk modeling must recognize up-regulation of protection
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HIERARCHY LEVEL RESPONSES IN BIOLOGICAL SYSTEMS
To fully appreciate the sequence of events to be reckoned with after
irradiation, the body may be viewed as a composite of hierarchy levels of
“protection” organization, as shown in Figure 2. 
Responses to the primary molecular perturbations and damages first
involve the cells that have experienced one or more microdose events
within a given period of time. The initially responding cells may transfer
their perturbation or damage to neighboring non-irradiated cells causing
so-called bystander effects, which may be damaging and/or induce
defenses (Mothersill and Seymour 2006). Similarly, energy deposition
events in the intercellular matrix may affect non-irradiated cells
(Barcellos-Hoff and Brooks 2001). These two damage categories are com-
monly referred to as non-targeted effects in contrast to targeted effects
referring to the immediate damage in irradiated cells. If damage
becomes lethal in many cells in a tissue, acute radiation effects may result
in acute illness, the symptoms of which depend on the organ where cell
death occurs; this again depends on the absorbed dose because stem cells
and differentiated cells in different organs have different radio-sensitivi-
ties (Hall and Giaccia 2005; Fliedner et al. 2005). On the other hand, indi-
vidual cells having escaped lethal radiation effects, may still suffer malig-
nant transformation and eventually cause cancer with metastases. The
L. E. Feinendegen and others
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FIGURE 2: The body may be viewed being organized in hierarchical levels with increasing complex-
ity from bottom up. Intricate signaling within and between the various levels always involves cells. The
three principal signaling loops assure functional integrity of the body in the face of abundant threats
by toxic impacts from external and internal sources. 
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mechanisms of malignant transformation may include genomic instabili-
ty induced in exposed cells and “handed down” to the cell’s progeny over
several cell generations (Kadhim et al. 2006; Dziegielewski et al. 2008). 
Whereas the incidence of immediate DNA damage rises linearly with
dose, damages to DNA and cells from both by-stander and matrix effects,
and from genomic instability appear to have different dose thresholds,
probably below 150 mGy, and reach plateaus with increasing dose at
about 300 to 500 mGy. Immediate plus secondary damages to DNA and
cells, i.e. targeted and non-targeted radiation damages, all induce the
body’s defenses against such damaging events and damage propagation
to subsequent higher levels at tissues and the whole organism. 
THREE EXAMPLES OF PHYSIOLOGICAL DEFENSES OF COMPLEX BIO-
LOGICAL SYSTEMS
The extent of the targeted and non-targeted damage and its propa-
gation in cells, tissues and finally perhaps the whole body depend on the
type and degree of initial homeostatic perturbations and on the tolerance
of homeostatic controls and defenses that operate at sequentially higher
levels. Signaling loops coordinate controls within and between cells,
between cells of different tissues and/or organs, and within the whole
body, all are subject to gene modulations (Guyton and Hall 2005).
Therefore, certain defects in the involved genes may change individual
susceptibility to radiation drastically.
One may, in general, discern three prototypes of defense: physical-
static ones, and two metabolic-dynamic ones, usually involving enzymes
according to the individual’s genome. 
The physical-static barriers prevent impacts from changing matter,
from disrupting a material structure and consequently its function in a
system. For instance, a certain impact size, i.e., force is required to move
a body such as a stone on a surface in a given direction—well known and
described by physical laws. Similarly, a certain target-specific impact is
needed to injure the skin, or to kill a cell, or to break an inter-atomic
bond in a molecule. Moreover, tissue damage only occurs if a minimum
number of cells that are essential to structure and function have been
removed from their structural and functional places in tissue. Obviously,
there are thresholds for a force to overcome a physical-static barrier
before an effect can be registered at the impacted object. With increasing
magnitude of the impact the effect becomes larger or more severe and
eventually reaches a maximum. The corresponding impact-size-effective-
ness function that describes the relationship between impact-size and
severity of effect gives graphically a sigmoid shaped curve. 
Metabolic defenses can operate practically instantly at all levels of
organization in normal organisms against potentially life-threatening
Low-dose cancer risk modeling must recognize up-regulation of protection
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events, which are shown schematically in Figure 3. An example of defense
at the tissue level presents the protection by the skin against manifold dif-
ferent types of impacts. If injured, the normal skin promptly initiates pro-
tective responses leading, for instance, to wound healing through signal-
induced cell death, cell necrosis, phagocytosis, cell proliferation and dif-
ferentiation. At the molecular level, DNA damages of various kinds, be
they base alterations, strand breaks or intermolecular linkages, induce a
large number of specific repair responses (Hall and Giaccia 2005) 
With a holistic view of systemic function at various levels one may dis-
tinguish the following prompt metabolic-dynamic defenses, as shown in
Figure 3. These may be grouped into three categories (Feinendegen et al.
1995; 1999; 2004;; 2007a,b; Feinendegen and Neumann 2005):
a) defenses by scavenging mechanisms at the atomic-molecular level; 
b) molecular repair, especially of DNA, with reconstitution of essential
cell constituents and functions; 
c) removal of damaged cells by induced cell death, i.e., apoptosis, cell
necrosis, and an immediate immune response in an immunized body,
with phagocytosis of killed cells, or by cell proliferation towards senes-
cence.
L. E. Feinendegen and others
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FIGURE 3: Threats at the various organizational levels of the body are met by physical-static and
metabolic-dynamic defenses against damaging impact, damage creation and damage propagation.
These defenses are successful if they restore homeostasis, from the molecular to the tissue-organ
level. Only when the defense barriers are overcome, pathology develops with acute and late health
effects, such as cancer. The individual defenses respond with individual probabilities 
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In this context it is important to adhere to careful definitions. Thus,
repair of a skin wound involves removal of damaged cells and cell debris
as well as cell proliferation and differentiation. Therefore, terms like
defense, repair and damage removal must be linked to the levels where
the damage occurs. Repair, damage removal, and replacement of dam-
aged and/or lost molecules and cells in the course of tissue reconstruc-
tion for maintenance of tissue function can be concordant events 
Like the physical-static barriers metabolic-dynamic barriers do not
operate at a level always proportional to the degree of perturbation. In
fact, these mechanisms of protection appear to allow perturbation to a
certain degree before they begin to act to restore homeostasis, and, thus,
prevent propagation of damage to successively higher levels of organiza-
tion. This means, an impact must be large enough to overcome a thresh-
old before structure and/or function are perturbed sufficiently to threat-
en the next higher level. There are many common daily examples with
this principle response pattern.
In general then, only when homeostatic perturbations overwhelm
structural and functional barriers at successive levels, from chemicals to
molecules, to cells, to tissue, etc., disease can develop.. 
The above described cascade of defenses also operates against local
damage and damage propagation from ionizing radiation. Since increas-
ing doses of ionizing radiation with large numbers of microdose events in
the exposed tissues eventually overwhelm barriers at all hierarchical lev-
els, high doses in large target volumes may allow damage at basic levels to
propagate with minimal or no inhibition, and thus to evolve into clinically
evident disease. As a consequence, many, but definitely not all, dose-
response functions expectedly tend to be linear at higher doses, but not
so at low doses. 
There is a second metabolic-dynamic type of barrier which becomes
activated by low-degree perturbations at a given level of biological organi-
zation. This barrier type is commonly referred to as stress response. It
expresses an adaptation of the exposed system to better withstand
renewed exposure to a potentially damaging impact by an agent that may
be identical to the initial agent or mimics this agent. A common experi-
ence of this type of adaptation is the development of callus in a chronically
burdened skin, or immunization for protecting the body against exposure
to an infecting agent. Another example is properly conducted physical
training to strengthen muscles and the cardiovascular system to improve
physical endurance and/or athletic performance. A fourth example is
properly dosed exposure to sunlight to induce tanning which will protect
against a higher-degree exposure to sunlight by reducing the probability
of sun burn. Adaptive protections result from up-regulation of existing cas-
cades of metabolic-dynamic barriers described above. In contrast to the
promptly acting barriers, however, adaptive protections appear after a
Low-dose cancer risk modeling must recognize up-regulation of protection
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delay and increase to a maximum after one or repetitive stimulating
impacts followed by a decline after the stimulus has disappeared. This
decline is comparatively slow and may be observed for months to more
than a year; some immunizations even protect for a life time. 
Thus, low-dose irradiations, in contrast to high doses, can cause adap-
tive protections to function in cells, tissues, animals and humans. There
is a wide-spread misunderstanding of these low-dose induced adaptive
protections only to act against renewed radiation and not to radiomimet-
ic perturbations. Yet, adaptive protections defend also against other
agents that cause DNA damage (Wolff et al. 1988), as referred to below. 
LOW-DOSE INDUCED ADAPTIVE PROTECTIONS
Over the past three decades, experimental data in cultured cells and
in animals have established that low doses of low-LET type radiation can,
with a delay of several hours after a single irradiation, up-regulate physi-
ological defenses discussed above (Feinendegen et al. 1999; 2004;
2007a,b; Mullenders et al. 2009, Tubiana et al. 2009). Up-regulation was
quantified, for instance, regarding: scavenging of ROS that lasted for
more than 10 hours (Zamboglou et al. 1981; Feinendegen et al.1984;1995;
Hohn-el-Karim et al. 1990); DNA repair lasting for several days (Olivieri et
al. 1984; Wolff et al.1988); apoptosis to reach a maximum about 4 hours
after single exposure and to continue being elevated for more than 2
weeks following cessation of repetitive low-dose exposures (Kondo 1988;
Fujita et al. 1998) and an increased immune response lasted for months
and even more than a year with concomitant reduction, for instance, of
metastases (James and Makinodan 1990; Tubiana et al. 2005; 2009). An
integrated effect of adaptive protections shows in the degree of reduction
of neoplastic transformations in cultured cells as well as primary cancer
and metastases in animals following a single low-dose irradiation (Azzam
et al. 1996; Feinendegen et al. 2004; Mitchel et. al. 2003; 2008; Elmore et
al. 2009). In cultured cells a single low-dose, low-LET irradiation reduced
neoplastic transformation to about 30 % of the transformation incidence
in non-irradiated controls; and a threshold for neoplastic transformation
existed in such cells even after high cell doses from accelerated particles
(Azzam et al. 1996; Elmore et al. 2009). 
Like in the case of immediately protecting responses, adaptive pro-
tections do not necessarily develop proportionally to the degree of the
perturbing event. Adaptive protections are related to dose in that they
appear after single exposure at a low threshold of cell dose, increase to a
dose around 100 mGy, then disappear as doses increase beyond 200 mGy
of low-LET radiation and are hardly, or not at all, seen above about 500
mGy (Feinendegen et al. 1996; 1999; 2007a). An exception is apoptosis,
in that its incidence apparently increases linearly over a certain dose
L. E. Feinendegen and others
238
12
Dose-Response: An International Journal, Vol. 8 [2014], Iss. 2, Art. 9
https://scholarworks.umass.edu/dose_response/vol8/iss2/9
region beyond single doses of 500 mGy, whereas at doses below about 100
mGy, there is evidence of apoptosis incidence to fall below the control
level (Liu et al. 1996). In addition, unrepairable DNA damage obviously
predisposes cells to induction of apoptosis more frequently than normal
cells (Chandra et al. 2000). High-dose irradiation of mammals with alpha-
particles in vivo suggests induction of the body’s immune responses via
the activation of immune cells in the neighborhood of high-LET dam-
aged single cells (Harder 2008). 
Adaptive responses are well known, for instance, following so-called
oxygen stress (Chandra et al. 2000; Finkel and Holbrook 2000: Sen et al.
2000), which also may in part be associated with radiation induced adap-
tive protection (Feinendegen et al. 1995, 2000; Feinendegen 2002: Hohn-
el-Karim et al. 1990). As referred to above, a normal average cell experi-
ences a mitochondrial leak of about 109 ROS molecules per day, i.e. about
100 ROS molecules per millisecond, in the cytoplasm outside mitochon-
dria, mainly from metabolic reactions; and additional small ROS bursts
come from various responses to external cell signaling (Pollycove and
Feinendegen 2003; Sen et al. 2000). An average microdose event, for
instance produced by 100 kVp x-rays, creates about 150 ROS in the hit
cell within a fraction of a millisecond. Both metabolic and radiation
induced ROS can trigger oxidative stress responses in terms of adaptive
protections depending on concentrations, species, tissues and cells
(Finkel and Holbrook 2000; Feinendegen and Neumann 2000;
Feinendegen 2002). In this context, normal background irradiation with
its causing single microdose events per cell several times a year, as
explained above, should be seen also as inducers of maintaining home-
ostasis (Feinendegen 2002), for instance by inducing apoptosis of pre-
damaged cells (Chandra et al. 2000). 
To repeat, adaptive protections were assumed initially to be confined to
DNA repair following renewed irradiation (Olivieri et al. 1984; Wolff et al.
1988). Yet, it has become clear that the delayed stimulated protections may
not only involve all physiological defenses but also operate against non-radi-
ogenic damage, such as damage from endogenous toxins, like ROS
(Chandra et al. 2000; Feinendegen et al. 1995) and from chemical muta-
gens (Wolff et al. 1988). Cells rarely can afford the energy “costs” associat-
ed with creating a special response to a rare or unique perturbation. The
broad effectiveness of adaptive protections at all levels of biological organ-
ization, against both radiogenic and non-radiogenic damage, expresses a
hormetic response, and is crucial in estimating probabilities of late radia-
tion effects such as cancer, as will be discussed in more detail below. 
The effect of cascades of homeostatic responses against propagation
of primary damage at the DNA level to successive higher levels of the
cell’s organization may be expressed by a set of equations shown schemat-
ically in Figure 4.
Low-dose cancer risk modeling must recognize up-regulation of protection
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PHYSIOLOGICAL DEFENSES AGAINST CANCER
The various physiological barriers against damage and damage prop-
agation sketched out above also operate in the course of oncogenesis, as
illustrated in Figure 5. Even if the protective mechanisms against cancer
still are not fully understood, their effects are obvious. An illustrative
example is the very low probability of a radiation induced average DNA
double strand break in a potentially oncogenic blood-forming human tis-
sue stem cell to bring about a lethal leukemia. This probability has been
estimated to be close to 10–12 (Feinendegen et al. 1995). The claim that
even a single DNA double strand break, however grave, in a human stem
cell may lead to cancer is scientifically unjustified. 
Low-dose induced cancer is, nevertheless, assumed by many to
increase proportionally with dose. This opinion hypothesizes that irre-
spective of dose a certain, however small, fraction of radiogenically trans-
formed cells escapes all barriers and expands into clinical cancer. The
probability of such an escape of a transformed cell may be estimated from
experimental and epidemiological observations. Thus, the probability of
neoplastic transformation in a cell in vitro is about 10–5 per low-LET
microdose event (Hall and Giaccia 2005) and the probability of lethal
leukemia per low-LET microdose event in a human hemopoietic stem
cell in vivo is a about 10–14 (Feinendegen et al. 1995). Assuming that the
in vitro probability also applies in vivo, the quotient 10–14 / 10–5 is about
L. E. Feinendegen and others
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FIGURE 4: Damage propagation to successive higher level of organization, from DNA, to cells, to tis-
sue, and the effect of protection at the cell and tissue levels may be expressed schematically by a sim-
ple set of equations. 
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10–9 and expresses the probability of the affected cell to escape all in vivo
defense mechanisms. The claim of constancy of the effectiveness of
defense barriers in vivo irrespective of dose is contradicted by the
induced adaptive protections following low doses but not high doses. 
DAMAGE AND PROTECTION IN THE “DUAL-PROBABILITY-MODEL” OF
CANCER RISK
In the attempt to assess cancer risk from low dose exposure realisti-
cally, both probabilities, of damage and of protection after low-dose irra-
diation, need to be taken into consideration. To do so coherently and
effectively, one should try to choose a model into which all the phenom-
ena that affect low-dose responses can be accommodated. Instead of
examining the various types of protections individually (Heidenreich and
Hoogenweem 2001; Schöllnberger et al. 2005), an average degree of pro-
tection may be preferable for modeling (Feinendegen et al. 1995; Scott
2004; Leonard 2007), in which all mechanisms are incorporated and
yield together a probability value between 0 and 1, i.e. between no and
full protection against a risk of induction of a clinical cancer. 
The model of choice here derives from an approach proposed in
1995 (Feinendegen et al. 1995). It rests on the dual effect of low doses in
both causing damage and protection (Feinendegen et al. 1999, 2000,
Low-dose cancer risk modeling must recognize up-regulation of protection
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FIGURE 5: The metabolic defenses also operate against the development of cancer. The various steps
to clinical cancer have individual probabilities. About 1 in 109 cancer cells may escape defense barri-
ers and cause clinical tumors and disseminated metastases. In industrialized countries, about 2-3 %
of cancer incidence is being attributed to background radiation, as is calculated on the basis of the
LNT hypothesis (adapted from Feinendegen et al. 2007a,b). 
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2004, 2007a,b). Figure 6 shows as a function of dose the model inputs of
the two opposing effects: a) the risk of cancer per unit dose, denoted by
Pind, mainly according to the LNT hypothesis; b) the probability of pro-
tection against cancer as a function of D and time of effectiveness tp,
denoted by Pap f (D; tp); with the base line showing the probability of life
time “spontaneous” cancer incidence that is observed in industrialized
countries, denoted by Pspo. Whereas the probability of protection accord-
ing to experimental observations rises with increasing doses to a maxi-
mum at about 100 to 200 mGy and then falls towards 0 as doses increase
beyond 300 mGy, the cancer risk rises linearly with dose if existing defens-
es against cancer are constant irrespective of dose. The figure includes
for cancer risk (red line) in the low dose range detrimental secondary
effects and repair induction. It also acknowledges adaptive protections
(green line) to appear at various low dose levels. Note that the scales for
the two probabilities, Pind and Pap f (D; tp) are independent of each other. 
In order to grasp the full consequence of low-dose induced adaptive
protections one must recall that the probability of endogenous, non-radi-
L. E. Feinendegen and others
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FIGURE 6: Schematic representation of the dual responses to single low doses feeding into the
“Dual-Probability-Model” in Figure 7: a) Low doses of ionizing radiation can up-regulate physiologi-
cal defenses with delay and some last beyond a year. The up-regulated defenses are also called adap-
tive protections and depend on dose D and on he time tp of their action: the probability of protec-
tion ranges from 0 – 1 and is Pap f (D; tp). b) The risk of radiation induced cancer assumes constant
defenses in the body at every dose D according to the LNT hypothesis and is expressed here by the
value of Pind per unit dose. - There are uncertainties at low dose levels shown by light dotted lines:
stemming from detrimental by-stander effects. genomic instability, as well as induction of repair; and
adaptive protections (adapted from Feinendegen et al. 2007a,b). Note that the scales of the two prob-
abilities Pind and Pap f (D; tp) are independent of each other. 
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ogenic, i.e. spontaneous, cancer (Pspo) at any time outweighs the proba-
bility of cancer from average background radiation, probably by a factor
of 30 to 50, if the LNT hypothesis is applied. It is to be noted that this
probability quotient is much lower than the quotient of about 1000 for
DNA double strand breaks (DSB) at any time from endogenous sources
to those from background radiation per average cell in an adult human
(Pollycove and Feinendegen 2003). This quotient of about 1000 only
expresses quantities. Yet, with respect to qualities a large percentage of
radiogenic DNA DSB are more complex, of the multi-damage type
(Nikjoo et al. 1999), and thus probably cause more cellular damage than
simple DSB from endogenous sources, perhaps by a factor of 20 to 30
(Pollycove and Feinendegen 2003).
Following a single low dose irradiation one may, thus, rightly assume
that the delayed and especially the long lasting adaptive protections oper-
ate mainly against endogenous cancer rather than cancer induced by irra-
diation (Feinendegen et al. 1995), as it is implied also by experimental evi-
dence (Mitchel et al. 2003, 2008). The risk of cancer following a single
low-dose exposure, therefore, would at every dose level be the difference
between the calculated radiogenic cancer risk at constant defenses, and
the prevented cancer risk being the sum of the probabilities of protection
against radiogenic as well as spontaneous cancer risks. This approach
gives the “Dual-Probability-Model” illustrated in Figure 7.
Thus, in accordance with previous reports (Feinendegen et al.
2007a,b, 2008) and considering here a balance of effectiveness of the
potential consequences from by-stander damage on the one hand, and
low-dose induced prompt repair on the other, 
R = clinically observed risk of cancer induced by a single dose
D
Pind D = radiation induced lethal cancer risk calculated with con-
stant defenses in the system, based on the LNT hypothe-
sis, from a single dose D, 
Pap f (D; tp) = probability of adaptive protection (0 -1) as function of D
and time of effectiveness tp, with target to be defined, 
Pspo = “spontaneous” life time cancer risk of the exposed indi-
vidual, in industrialized countries, 
then taking the targets of protection to be both Pspo and Pind D,
R = Pind D – Pap f (D; tp) (Pspo + Pind D) [1]
This “Dual-Probability-Model” allows to estimate the probability of adap-
tive protection, Pap f (D; tp), by assigning a value of R from epidemiolog-
ical data, and for Pind and Pspo, as follows: 
Low-dose cancer risk modeling must recognize up-regulation of protection
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Pind = 6 x 10
–5 induced lethal cancer risk / person / mGy, from
atom bomb data according to the LNT-hypothesis (Pre-
ston et al. 2004. 2007) 
Pspo = 2.5 x 10
–1 “spontaneous” cancer risk / individual life
time, in industrialized countries,
By taking into consideration that Pind is comparatively negligibly small vs.
Pspo, the risk estimate, Rx, at a given dose Dx from epidemiological studies
conforms to 
Rx = Pind Dx – Pap f (Dx; tp1) Pspo [2]
Rearranging equation [2] to 
Pap f (Dx; tp1) = (Pind Dx – Rx) / Pspo [3]
gives the probability of protection for a value of Rx at a given dose Dx. with
the protection target being the life time risk of cancer Pspo. For instance,
L. E. Feinendegen and others
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FIGURE 7: This Figure illustrates the applicability of the “Dual-Probability-Model” for assessing low-
dose cancer risk. - Adaptive protections, as shown in Figure 5 and 6, may also operate against non-
radiogenic damage and thus reduce “spontaneous cancer. The product of the probability of protec-
tion against spontaneous cancer, from 0 to 1, and the probability of spontaneous cancer gives the
probability of cancer prevention The clinically observed cancer risk R, then, is the difference
between the probabilities of radiation induced cancer and of prevented cancer, given by the solid
line. Assuming here a maximum value of Pap f(D, tp) at 100 to 200 mGy, the reduction of cancer risk
to and below the spontaneous risk appears as an obvious hormetic effect, despite the low values of
Pap f(D, tp), see table 2 and 3 (adapted from Feinendegen et al. 2007a,b). 
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letting the cancer risk Rx be 0 at 100 mGy, as compatible with most epi-
demiological data, and inserting the above defined values of Pspo, and of
Pind for 100 mGy being approximately 6 x 10
–3, the value of Pap f (Dx; tp1)
becomes
Pap f (Dx; tp1) = (6 x 10
–3 – 0) / 2.5 x 10–1 [4]
or
Pap f (Dx; tp1) = 2.4 x 10
–2 [5} 
In other words, a very small degree of adaptive protection covering about
2.4 % of a person life time cancer risk in industrialized countries would
be sufficient to balance the assumed cancer risk at 100 mGy, based on the
LNT hypothesis. 
In fact, the application of the dose effect curve for overall protection
as seen in Figure 6, together with the degree of protection in equation 5
to an epidemiologically estimated R value of 0 at 100 mGy, and assuming
that the maximum adaptive protection here occurs at 100 to 200 mGy,
yields a hormetic effect up to 100 mGy, as illustrated by the solid line in
Figure 7 The numerical values of the data in Figure 7 are in Table 2,
where at the given doses, however, effects of potential by-stander damage
and of prompt repair induction are omitted. 
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TABLE 2: Numerical values of the graph in Figure 7 for a given set of assumptions made on the basis
of experimental evidence, as explained in the text.
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If the degree of protection at 100 mGy would cover more than 2.4 %
of the life time cancer risk, the cancer risk after 100 mGy would fall below
the control value, and show up as a hormetic effect at 100 mGy.
Increasing Pind by a factor of 2 to a value of 12 x 10
–3, for instance by a
dominant by-stander damage, the protection probability would attain 4.8
% with Rx being 0 at 100 mGy. Assuming, for instance, dominating by-
stander damage at 50 mGy to increase Pind by a factor of 2 to 6 x 10
–3, with
Rx measured at 50 mGy being 0, the protection probability would become
again 2.4 % (see equation 4). 
The above listed low-dose induced reductions in the R values, even if
small, could add to the failure to observe any statistically significant increase
in radiation induced cancer risk at doses below about 100 mGy in epidemi-
ological analyses of exposed cohorts of humans. In fact, the registered data
in these analyses without data modeling at low doses indicate reduced can-
cer risks more frequently than increases of risk, with borderline statistical sig-
nificance (Pollycove and Feinendegen 2001; Preston et al. 2004).
According to above equation 4, the values of Pap f (Dx; tp1) that would
operate at different, epidemiologically estimated values of risk at 100
mGy are shown in Table 3. It is obvious that only less than 5 % of a per-
son’s life time risk of cancer need be covered by low-dose induced adap-
tive protection in order to produce a hormetic effect in terms of a reduc-
tion of the risk of spontaneous cancer at 100 mGy. These predictions of
L. E. Feinendegen and others
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TABLE 3: Numerical values of protections covering life time risk of spontaneous cancer in industri-
alized countries, as they are expected at 100 mGy with different values of risk estimated from epi-
demiological observations in irradiated populations.
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adaptive protection probabilities are well in line with experimental data
on protection effectiveness following single low-dose exposure.
CHRONIC IRRADIATION
The above model is applicable also to chronic or repetitive low dose
irradiation. During chronic irradiation individual microdoses from a given
quality of radiation occur in an exposed micromass at time intervals the
mean length of which is determined by the dose rate. For a given dose rate
of a defined radiation quality, there is a proportional relationship between
the mean microdose value, as shown in Table 1, and the mean time inter-
val between two consecutive microdose events. The higher the mean
microdose the longer is the mean time interval between two consecutive
microdose events at given dose rate. An example of stochastic distribution
of events per micromass and appropriate time intervals between two con-
secutive events for 250 kVp x-rays is shown schematically in Figure 8.
Radiation quality determines the range of the microdose values and
their time intervals and thus the probabilities of cellular reactions to the
individual microdoses, in terms of damage and protection. The time
interval between two consecutive microdose events in a given cell or cell
group then allows for the cellular responses to develop fully or not. Here
all types of responses need attention regarding the degree of damage and
its propagation. 
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FIGURE 8: Chronic irradiation conforms to repetitive irradiations of micromasses. Microdoses z
occur per micromass over time stochastically with various values, upper part, according to their spec-
trum depending on radiation quality, lower part for 250 kVp x-rays. 
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To appreciate biological effects of dose rates or repetitive irradiations
properly it appears paramount to consider the following questions: What
are the individual microdose values that may cause damage and induce
prompt metabolic defenses and adaptive protections at a given time inter-
val between consecutive events; and what are the values of the time inter-
vals that allow for defined damage manifestation and prompt and late
responses to individual microdose events. The answers to these questions
are very fragmentary, yet appear crucial in understanding results both of
low dose-rate experiments (Vilenchik and Knudson 2000; Ishizaki et al.
2004) and of epidemiological investigations from cohorts of chronically
exposed mammals and people with reduced rather than increased cancer
incidences (Tanooka 2001; Mitchel et al. 2003, 2008; Cardis et al. 2007;
Nair et al. 2009). A schematic display of possible consequences of differ-
ent low dose-rate scenarios is in Figure 9. 
CONCLUSION
Current radiogenic cancer epidemiology reports cannot overcome
their statistical constraints and these papers do not assure the validity of
the LNT-hypothesis at low doses. In fact, the LNT hypothesis is inconsis-
L. E. Feinendegen and others
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FIGURE 9: The biological risk of chronic irradiation depends of the values of microdoses and the
time interval between consecutive microdose events. Mean values for both may be used for assessing
risk. The term “cancer risks” here expresses the probability of cancer induction by the hit cell at the
time during exposure, with the added time intervals allowing for repair and protection. Shown
schematically are three scenarios: 1. where protection outweighs damage; 2. where protection equals
damage; 3. where damage outweighs protection. 
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tent with many experiments, both in the laboratory and in the human
exposure realms. 
Low doses may cause at the molecular level, especially in the DNA,
targeted and non-targeted effects. These may propagate in succession to
increasingly complex levels of biological organizations, from molecules to
cells, to tissues, and the whole body. In this fashion it seems opportune to
distinguish between trigger and responses with the latter encompassing
both increased perturbations, as well as defenses to restore homeostasis.
There appear to be three principle types of defense barriers against dam-
age and its propagation: physical-static ones, and two metabolic-dynamic
defenses. One of the latter type operates promptly and the other by way
of delayed up-regulation of protection at successive levels of organization,
i.e., by adaptive protections. These operate also against a multitude of
constantly arising endogenous mutagenic toxins and their consequences.
The actual observed cancer risk of low-dose irradiation, thus, appears to
express the balance between cancer induction and cancer prevention by
metabolic-dynamic defenses through prompt and adaptive protections.
The consequences of these experimental findings are not contradicted by
epidemiological data on radiation induced cancer from low doses. 
The type and extent of cell defenses are under genetic control. Thus,
effects of low-dose irradiation are expected to vary among individuals,
and may even become predictable by individual gene-expression profiles.
This information promises to have clinical applications, for instance, in
treating cancer with low-dose irradiation. 
Radiation biology has advanced to provide sufficient data that justify
the rejection of the validity of the LNT-hypothesis in concepts of collec-
tive dose or collective effective dose for predicting cancer risks of single,
chronic or repetitive low-level exposures. 
It is suggested that an appropriate consensus conference provides
new guidance based on scientific evidence in order to arrive at optimal
radiation risk estimates with their impact on radiation protection.
Frequently voiced arguments that the new low-dose experimental
data are either irrelevant, or questionable, or irreproducible are not in
line with scientific methodology. In fact, these arguments apply more to
the claimed constructs that support the LNT hypothesis, a hypothesis
which must constantly be examined as such—a hypothesis always to be
tested by new data—not in law.
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